A summary of the “Medicina Personalizada y Computación Cuántica: Simulaciones a Medida de tu Genoma” (Oct 2026)
Here's a summary of the “Medicina Personalizada y Computación Cuántica: Simulaciones a Medida de tu Genoma” post from Hive (27 Oct 2026): Key Takeaways from the Article What works today (without quantum): Classical pharmacogenomics (CYP2D6, CYP2C19, VKORC1 genes for drug metabolism) Tumor sequencing for targeted cancer therapies Risk panels for immune response, coagulation, drug processing Current limitations: These are statistical/pattern-based approaches that work well for populations but have variable individual responses. Complex biological interactions are hard to model classically. How quantum computing could change things: Molecular simulation by genome: Quantum computers can natively simulate quantum systems, potentially modeling drug-receptor binding, protein folding, and metabolism for specific genomes with far greater precision than classical computers. Three concrete research areas (still experimental): Oncology precision: Simulating binding energies of cancer dr...
